BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38272015)

  • 1. Prevalence and Trajectories of Post-COVID-19 Neurological Manifestations: A Systematic Review and Meta-Analysis.
    Giussani G; Westenberg E; Garcia-Azorin D; Bianchi E; Yusof Khan AHK; Allegri RF; Atalar AÇ; Baykan B; Crivelli L; Fornari A; Frontera JA; Guekht A; Helbok R; Hoo FK; Kivipelto M; Leonardi M; Lopez Rocha AS; Mangialasche F; Marcassoli A; Özdag Acarli AN; Ozge A; Prasad K; Prasad M; Sviatskaia E; Thakur K; Vogrig A; Leone M; Winkler AS;
    Neuroepidemiology; 2024; 58(2):120-133. PubMed ID: 38272015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis.
    Premraj L; Kannapadi NV; Briggs J; Seal SM; Battaglini D; Fanning J; Suen J; Robba C; Fraser J; Cho SM
    J Neurol Sci; 2022 Mar; 434():120162. PubMed ID: 35121209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Neurological Sequelae Among Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.
    Patel UK; Mehta N; Patel A; Patel N; Ortiz JF; Khurana M; Urhoghide E; Parulekar A; Bhriguvanshi A; Patel N; Mistry AM; Patel R; Arumaithurai K; Shah S
    Cureus; 2022 Sep; 14(9):e29694. PubMed ID: 36321004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological outcomes 1 year after COVID-19 diagnosis: A prospective longitudinal cohort study.
    Rass V; Beer R; Schiefecker AJ; Lindner A; Kofler M; Ianosi BA; Mahlknecht P; Heim B; Peball M; Carbone F; Limmert V; Kindl P; Putnina L; Fava E; Sahanic S; Sonnweber T; Löscher WN; Wanschitz JV; Zamarian L; Djamshidian A; Tancevski I; Weiss G; Bellmann-Weiler R; Kiechl S; Seppi K; Loeffler-Ragg J; Pfausler B; Helbok R
    Eur J Neurol; 2022 Jun; 29(6):1685-1696. PubMed ID: 35239247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 associated central nervous system manifestations, mental and neurological symptoms: a systematic review and meta-analysis.
    Soltani S; Tabibzadeh A; Zakeri A; Zakeri AM; Latifi T; Shabani M; Pouremamali A; Erfani Y; Pakzad I; Malekifar P; Valizadeh R; Zandi M; Pakzad R
    Rev Neurosci; 2021 Apr; 32(3):351-361. PubMed ID: 33618441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome predictors of post-COVID conditions in the European Academy of Neurology COVID-19 registry.
    Leone MA; Helbok R; Bianchi E; Yasuda CL; Konti M; Ramankulov D; Lolich M; Lovrencic-Huzjan A; Kovács T; Armon C; Cotelli MS; Cavallieri F; Grosu O; Kiteva-Trenchevska G; Rodriguez-Leyva I; Boldingh M; Brola W; Maia LF; de Seabra MML; Davidescu EI; Popescu BO; Kopishinskaia S; Bassetti CLA; Moro E;
    J Neurol; 2024 Jun; 271(6):3153-3168. PubMed ID: 38436682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.
    Alkodaymi MS; Omrani OA; Fawzy NA; Shaar BA; Almamlouk R; Riaz M; Obeidat M; Obeidat Y; Gerberi D; Taha RM; Kashour Z; Kashour T; Berbari EF; Alkattan K; Tleyjeh IM
    Clin Microbiol Infect; 2022 May; 28(5):657-666. PubMed ID: 35124265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013665. PubMed ID: 33620086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological symptoms of COVID-19 infection; a cross-sectional study on hospitalized COVID-19 patients in Iran.
    Nejad JH; Allahyari F; Hosseinzadeh R; Heiat M; Ranjbar R
    Clin Neurol Neurosurg; 2021 Nov; 210():106985. PubMed ID: 34700274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological and Psychiatric Manifestations of Post-COVID-19 Conditions.
    Jung YH; Ha EH; Park J; Choe KW; Lee WJ; Jo DH
    J Korean Med Sci; 2023 Mar; 38(11):e83. PubMed ID: 36942392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and co-occurrence of cognitive impairment in children and young people up to 12-months post infection with SARS-CoV-2 (Omicron variant).
    Foret-Bruno P; Shafran R; Stephenson T; Nugawela MD; Chan D; Ladhani S; McOwat K; Mensah A; Simmons R; Fox Smith L; D'oelsnitz A; Xu L; Dalrymple E; Heyman I; Ford T; Segal T; Chalder T; Rojas N; Pinto Pereira SM;
    Brain Behav Immun; 2024 Jul; 119():989-994. PubMed ID: 38735404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological Sequelae of COVID-19.
    Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
    J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological Manifestations in COVID-19 Infection: A Systematic Review and Meta-Analysis.
    Collantes MEV; Espiritu AI; Sy MCC; Anlacan VMM; Jamora RDG
    Can J Neurol Sci; 2021 Jan; 48(1):66-76. PubMed ID: 32665054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.
    Rogers JP; Chesney E; Oliver D; Pollak TA; McGuire P; Fusar-Poli P; Zandi MS; Lewis G; David AS
    Lancet Psychiatry; 2020 Jul; 7(7):611-627. PubMed ID: 32437679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term neurological manifestations of COVID-19: prevalence and predictive factors.
    Pilotto A; Cristillo V; Cotti Piccinelli S; Zoppi N; Bonzi G; Sattin D; Schiavolin S; Raggi A; Canale A; Gipponi S; Libri I; Frigerio M; Bezzi M; Leonardi M; Padovani A
    Neurol Sci; 2021 Dec; 42(12):4903-4907. PubMed ID: 34523082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of Neurologic Manifestations in COVID-19: A Systematic Review and Meta-analysis.
    Misra S; Kolappa K; Prasad M; Radhakrishnan D; Thakur KT; Solomon T; Michael BD; Winkler AS; Beghi E; Guekht A; Pardo CA; Wood GK; Hsiang-Yi Chou S; Fink EL; Schmutzhard E; Kheradmand A; Hoo FK; Kumar A; Das A; Srivastava AK; Agarwal A; Dua T; Prasad K
    Neurology; 2021 Dec; 97(23):e2269-e2281. PubMed ID: 34635561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological Manifestations in Hospitalized Geriatric Patients With COVID-19 at King Abdulaziz Medical City in Jeddah, Western Region, Saudi Arabia From 2020 to 2021: A Cross-Sectional Study.
    Marghalani YO; Kaneetah AH; Khan MA; Albakistani AA; Alzahrani SG; Kidwai A; Alansari KW; Alhamid HS; Alharbi MH; Attar A
    Cureus; 2023 Sep; 15(9):e45759. PubMed ID: 37876390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological manifestations in patients with COVID-19: A systematic review and meta-analysis.
    Mahdizade Ari M; Mohamadi MH; Shadab Mehr N; Abbasimoghaddam S; Shekartabar A; Heidary M; Khoshnood S
    J Clin Lab Anal; 2022 May; 36(5):e24403. PubMed ID: 35385200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.